Methyl Trenbolone Inject 4 mg/ml (UP)

UNIQUE PHARMA QUALITY: Premium pharmaceutical grade injectable Methyl Trenbolone manufactured under strict GMP conditions with 99.8% purity verification.

Methyl Trenbolone Inject 4 mg/ml from Unique Pharma is a highly potent injectable anabolic-androgenic steroid. This injectable formulation of methyltrenbolone offers precise dosing in a convenient oil-based solution.

Key Characteristics

This injectable compound is administered via intramuscular injection and remains active in your system for approximately 2-3 days. Notable features include:

• Pharmaceutical grade manufacturing
• Batch-tested for purity and potency
• Consistent dosing per unit
• Optimal bioavailability via injection

Primary Benefits:

• Enhanced performance and recovery
• Quality-assured formulation
• Reliable and consistent results
• Professional-grade compound

Usage Guidelines

Unique Pharma Methyl Trenbolone Inject is suitable for experienced users who understand proper cycling protocols. This is an extremely potent compound — always consult with a healthcare professional before beginning any supplementation regimen.

Quality Assurance

Every Unique Pharma product undergoes comprehensive quality control including:

• Raw material verification
• In-process testing
• Final product analysis
• Stability testing

Warning: Keep out of reach of children. For adults only. Not intended for use by individuals under 18 years of age.

Related products

Other Unique Pharma Injectables

• Tren A 100(/products/tren-a-100mg-ml)
• Test E 250(/products/test-e-250mg-ml)
• Deca 200(/products/deca-200mgml)
• Boldenone 200(/products/boldenone-200mgml)

1. Description — Clinical summary

Methyl Trenbolone Inject 4 mg/mL (methyltrenbolone, metribolone) is an injectable formulation of one of the most potent synthetic anabolic-androgenic steroids known. Methyltrenbolone is a 17α-methylated derivative of trenbolone, originally studied in the 1960s as a reference androgen in receptor-binding research. It was never approved for human therapeutic use due to its extreme potency and hepatotoxicity profile.

Key points:

• Active compound: methyltrenbolone (17α-methyl-trenbolone), oil-based intramuscular injection.
• Concentration: 4 mg per mL — note the microgram-level effective doses compared to other steroids.
• Regulatory status: not approved for human medical use in most jurisdictions.
• This injectable formulation reduces first-pass hepatic metabolism compared to oral methyltrenbolone, though hepatotoxicity risk remains elevated due to the 17α-methyl group.

2. How does methyltrenbolone work?

Mechanism of action — pharmacology summary:

• Androgen receptor agonist: Methyltrenbolone has one of the highest binding affinities for the androgen receptor of any synthetic steroid, significantly exceeding testosterone and standard trenbolone.
• Non-aromatizing: Does not convert to estrogen via aromatase. However, progestogenic activity is present, which can contribute to gynecomastia through non-aromatase pathways.
• Anabolic/androgenic ratio: Extremely high anabolic and androgenic ratings. Even sub-milligram doses produce significant physiological effects.
• Metabolic effects: Potently increases nitrogen retention and protein synthesis. Markedly suppresses the hypothalamic-pituitary-gonadal (HPG) axis.
• Hepatic considerations: The 17α-methyl modification increases hepatotoxicity risk even in injectable form. Liver function monitoring is essential.

3. Dosage — usage guidelines

Important: Methyltrenbolone is not an approved human medication. No official medical dose exists.

A. Reported non-medical use patterns (informational only):

• Due to extreme potency, doses are measured in micrograms to low milligrams.
• Typical reported injectable patterns: 0.5-2 mg daily or every other day.
• Cycle length: commonly limited to 2-4 weeks due to hepatotoxicity concerns.
• Users generally combine with a testosterone base to maintain physiological hormone function.

B. Clinical management advice:

• If patient use is disclosed, document exact dose, frequency, duration, and concurrent substances.
• Obtain baseline liver function tests, CBC, lipid panel, and hormone levels.
• Counsel on immediate cessation if liver enzymes are elevated.

4. Side effects — common and rare adverse effects

A. Very common adverse effects:

• Severe HPG axis suppression; rapid and complete suppression of endogenous testosterone.
• Hepatotoxicity: elevated liver enzymes (AST, ALT), jaundice possible even at low doses.
• Androgenic effects: acne, oily skin, accelerated hair loss in predisposed individuals.
• Cardiovascular: adverse lipid changes, elevated blood pressure.
• Behavioral: irritability, aggression, insomnia, mood disturbances.
• Night sweats and increased body temperature.

B. Serious/rare effects:

• Cholestatic hepatitis and peliosis hepatis.
• Cardiomyopathy and left ventricular hypertrophy with prolonged use.
• Polycythemia increasing thrombotic risk.
• Progestogenic gynecomastia.
• Prolonged hypogonadism after discontinuation.

C. Monitoring:

• Liver function tests before, during (weekly), and after use.
• CBC with hematocrit, lipid panel, blood pressure monitoring.
• Serum testosterone, LH, FSH levels post-cycle.

5. Storage

• Store at controlled room temperature: 20-25°C (68-77°F). Brief excursions permitted between 15-30°C.
• Protect from light: keep in original packaging.
• Do not freeze oil-based injectable formulations.
• Keep vials sealed and sterile until use. Discard if solution appears cloudy, discolored, or contains particulates.
• Use single-use sterile needles and syringes. Never share injection equipment.
• Keep out of reach of children and unauthorized persons.
• Dispose of unused product and sharps per local regulations.